Rosenblatt Maintains Buy on Lumentum Holdings, Raises Price Target to $125
Rosenblatt analyst Michael Genovese maintains Lumentum Holdings (NASDAQ:LITE) with a Buy and raises the price target from $115 to $125.
Analyst Ratings For Lumentum Holdings
Lumentum Holdings (NASDAQ:LITE) has observed the following analyst ratings within the last quarter:
Northland Capital Markets Maintains Outperform on Lumentum Holdings, Raises Price Target to $120
Northland Capital Markets analyst Tim Savageaux maintains Lumentum Holdings (NASDAQ:LITE) with a Outperform and raises the price target from $110 to $120.
Lumentum Reports Strategic Collab With Ayar Labs To Supply External Light Sources For Co-Packaged Optical Interconnect Solutions
Lumentum and Ayar Labs collaborate on CW-WDM multi-source agreement (MSA) compliant external laser sources to power Ayar Labs’ optical I/O solution, further strengthening supply chain and ecosystem for applications
Merger Arbitrage Mondays – Healthcare Trust Of America To Combine With Healthcare Realty Trust
Merger activity increased last week with six new deals announced and six deals completed. Three of the six new deals announced were potential deals in the works.
Healthcare Trust of America (NYSE: HTA)
Morgan Stanley Maintains Equal-Weight on Lumentum Holdings, Raises Price Target to $97
Morgan Stanley maintains Lumentum Holdings (NASDAQ:LITE) with a Equal-Weight and raises the price target from $91 to $97.
Rosenblatt Maintains Buy on Lumentum Holdings, Raises Price Target to $115
Rosenblatt analyst Hans Mosesmann maintains Lumentum Holdings (NASDAQ:LITE) with a Buy and raises the price target from $105 to $115.
Raymond James Maintains Outperform on Lumentum Holdings, Raises Price Target to $99
Raymond James analyst Simon Leopold maintains Lumentum Holdings (NASDAQ:LITE) with a Outperform and raises the price target from $96 to $99.
